Speak directly to the analyst to clarify any post sales queries you may have.
The study considers a detailed scenario of the present pharmaceutical packaging & labeling market and its market dynamics for 2023−2028 in the US. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent players operating in the market.
MARKET DEFINITION
Pharmaceutical packaging is the packaging process for pharmaceutical preparations, and it is an integral part of the pharmaceutical product. Packaging is often involved in dosing, dispensing, and using the pharmaceutical product. Pharmaceutical Labeling refers to the process of adding labels to pharmaceutical products to facilitate the identification and understanding of important information for end-users.KEY HIGHLIGHTS
- The US pharmaceutical packaging & labeling market was valued at $29.95 billion in 2022 and is projected to reach $38.57 billion in 2028, with a compound annual growth rate (CAGR) of 4.30%, during the study period.
- In 2022, the US accounted for a significant market share in the North America Pharmaceuticals packaging & labeling market, owing to increasing demand for prescription drugs, the presence of leading pharmaceutical players, well-developed infrastructure, high investments in drug development, and high per capita income.
- Primary Packaging accounted for the highest share of more than 70% in the US Pharmaceutical packaging market attributable to the growing demand for blister packs, bottles, vials, ampoules, pouches, sachet, and bags with the increasing demand for pharmaceuticals.
- Based on primary packaging type, the strips & blister packaging segment accounted for a 33.50% market share in the US pharmaceutical packaging market and dominated the other segments due to its wide usage as an essential primary packaging element for pharmaceutical products.
- Based on material type, the paper segment accounts for a 38.92% US Pharmaceutical packaging market share that can be attributable to its highest demand in secondary & tertiary packaging and increasing demand for recyclable materials.
- The pharmaceutical and biotech companies accounted for the highest share of more than 46% in the US Pharmaceutical packaging market, which is owing to the growing aged population, growing demand for branded drugs, OTC drugs, and specialty medicines, increasing patent expiring drugs, and higher drug prices.
- Amcor, Aptar Group, Berry Global, Laser Gerresheimer, and WestRock are the leading US Pharmaceutical Packaging players. The market offers tremendous growth opportunities for existing and future/emerging players because of innovations in oncology, autoimmune and diabetes treatment, chronic ailments, and rare diseases.
KEY VENDORS LIST
- Amcor
- Aptar
- Berry Global
- Gerresheimer
- WestRock Pharmaceuticals
- Avery Dennison
- CCL Industries
- Essentra
- 3M Company
- SATO
- ACG
- Airnov
- Becton, Dickinson and Company (BD)
- Bilcare
- Borosil
- Drug Plastic Group
- DWK Life Sciences
- Meghmani Group
- Nolato
- Nemera
- Renolit
- Specialty Polyfilms
- Vetter
- Korber
- Consolidated Label Co.,
- Multi-Color Corp
REPORT HIGHLIGHTS
PRODUCT SEGMENTATION & FORECAST
- Packaging type
- Primary
- Secondary
- Tertiary
- Material type
- Paper
- Glass
- Plastic
- Others
- End-user type
- Pharmaceuticals & Biotech Companies
- CMOs/CDMOs
- Others
- Label type
- Pressure-Sensitive Labels
- Sleeve Labels
- Others
- Application
- Instructional
- Decorative
- Functional
- Promotional
- Others
- Product type
- Bottles, Containers & Jars
- Ampoules & Vials
- Strips & Blisters
- Others
MARKET STRUCTURE
- Market Dynamics
- Competitive Landscape of Pharmaceutical packaging & Labeling Market
- Key Vendors
- Other Prominent Vendors
Table of Contents
Companies Mentioned
- Amcor
- Aptar
- Berry Global
- Gerresheimer
- WestRock Pharmaceuticals
- Avery Dennison
- CCL Industries
- Essentra
- 3M Company
- SATO
- ACG
- Airnov
- Becton, Dickinson and Company (BD)
- Bilcare
- Borosil
- Drug Plastic Group
- DWK Life Sciences
- Meghmani Group
- Nolato
- Nemera
- Renolit
- Specialty Polyfilms
- Vetter
- Korber
- Consolidated Label Co.,
- Multi-Color Corp
Methodology
Our research comprises a mix of primary and secondary research. The secondary research sources that are typically referred to include, but are not limited to, company websites, annual reports, financial reports, company pipeline charts, broker reports, investor presentations and SEC filings, journals and conferences, internal proprietary databases, news articles, press releases, and webcasts specific to the companies operating in any given market.
Primary research involves email interactions with the industry participants across major geographies. The participants who typically take part in such a process include, but are not limited to, CEOs, VPs, business development managers, market intelligence managers, and national sales managers. We primarily rely on internal research work and internal databases that we have populated over the years. We cross-verify our secondary research findings with the primary respondents participating in the study.
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 127 |
Published | August 2023 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 29.95 Billion |
Forecasted Market Value ( USD | $ 38.56 Billion |
Compound Annual Growth Rate | 4.3% |
Regions Covered | United States |
No. of Companies Mentioned | 26 |